Incidence of oral anticoagulant interruption among stroke patients with atrial fibrillation and subsequent stroke
Background and purpose We analyzed the incidence and causes of oral anticoagulant (OAC) cessation and subsequent stroke after OAC withdrawal in a cohort of Korean stroke patients with atrial fibrillation. Methods The Korean Atrial Fibrillation Evaluation Registry in Ischemic Stroke patients (K‐ATTEN...
Gespeichert in:
| Veröffentlicht in: | European journal of neurology 2020-05, Vol.27 (5), p.900-902 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 902 |
|---|---|
| container_issue | 5 |
| container_start_page | 900 |
| container_title | European journal of neurology |
| container_volume | 27 |
| creator | Kim, J.‐M. Park, K.‐Y. Yu, I.‐W. Song, T.‐J. Kim, Y.‐J. Kim, B. J. Heo, S. H. Jung, J.‐M. Oh, K.‐M. Kim, C. K. Yu, S. Park, J.‐H. Choi, J. C. Park, M.‐S. Kim, J.‐T. Choi, K.‐H. Hwang, Y.‐H. Chung, J.‐W. Bang, O. Y. Kim, G.‐M. Seo, W.‐K. |
| description | Background and purpose
We analyzed the incidence and causes of oral anticoagulant (OAC) cessation and subsequent stroke after OAC withdrawal in a cohort of Korean stroke patients with atrial fibrillation.
Methods
The Korean Atrial Fibrillation Evaluation Registry in Ischemic Stroke patients (K‐ATTENTION) is a multicenter cohort study, merging stroke registries from 11 tertiary centers in Korea. The number of OAC interruption episodes and the reasons were reviewed from hospital records. Stroke after OAC withdrawal was defined when a patient experienced ischaemic stroke within 31 days after OAC withdrawal. Clinical variables were compared between patients who experienced stroke recurrence during OAC interruption and those who did not experience recurrence.
Results
Among 3213 stroke patients with atrial fibrillation, a total of 329 episodes of OAC interruption were detected in 229 patients after index stroke (mean age 72.9 ± 8.3 years, 113 female patients). The most frequent reason for OAC withdrawal was poor compliance [103 episodes (31.3%)] followed by extracranial bleeding [96 episodes (29.2%)]. Stroke after OAC withdrawal was noted in 13 patients. Mean age, vascular risk factor profile and mean CHA2DS2‐VASc score were not significantly different between patients with and without recurrent stroke.
Conclusions
A considerable number of stroke patients with atrial fibrillation experienced temporary interruption of OAC after index stroke, which was associated with stroke recurrence of 4.0 cases per 100 interruption episodes. |
| doi_str_mv | 10.1111/ene.14175 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2356607353</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2391804710</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3535-4c894eae9d1bf2eae7e9196fc6721b287181757e653c1b736734a22316cc25293</originalsourceid><addsrcrecordid>eNp1kU9P3DAQxa2qVfnTHvoFkKVe6CHgsRM7OSK0FCREL_QcOd4JNc3ai-0I8e0Zmi0HJOYy7_CbN2M_xr6BOAGqUwx4AjWY5gPbh1q3FSgFH0mrBqoGBOyxg5zvhRDSSPGZ7SkpdG1quc8eroLzawwOeRx5THbiNhTvor2bJ1Lch4IpzdviY-B2E8MdzyXFv8i3tngMJfNHX_5wW5Kn4dEPyU-TXfCw5nkeMj7MBO7mvrBPo50yft31Q_b7YnV7flld__p5dX52XTnVqKaqXdvVaLFbwzBKEgY76PTotJEwyNZASw82qBvlYDBKG1VbKRVo52QjO3XIjhffbYq0P5d-47NDui1gnHMvVaO1MLSM0O9v0Ps4p0DXEdVBK2oDgqgfC-VSzDnh2G-T39j01IPoX3LoKYf-Xw7EHu0c52GD61fy_8cTcLoAj37Cp_ed-tXNarF8BgeTkl0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2391804710</pqid></control><display><type>article</type><title>Incidence of oral anticoagulant interruption among stroke patients with atrial fibrillation and subsequent stroke</title><source>Access via Wiley Online Library</source><creator>Kim, J.‐M. ; Park, K.‐Y. ; Yu, I.‐W. ; Song, T.‐J. ; Kim, Y.‐J. ; Kim, B. J. ; Heo, S. H. ; Jung, J.‐M. ; Oh, K.‐M. ; Kim, C. K. ; Yu, S. ; Park, J.‐H. ; Choi, J. C. ; Park, M.‐S. ; Kim, J.‐T. ; Choi, K.‐H. ; Hwang, Y.‐H. ; Chung, J.‐W. ; Bang, O. Y. ; Kim, G.‐M. ; Seo, W.‐K.</creator><creatorcontrib>Kim, J.‐M. ; Park, K.‐Y. ; Yu, I.‐W. ; Song, T.‐J. ; Kim, Y.‐J. ; Kim, B. J. ; Heo, S. H. ; Jung, J.‐M. ; Oh, K.‐M. ; Kim, C. K. ; Yu, S. ; Park, J.‐H. ; Choi, J. C. ; Park, M.‐S. ; Kim, J.‐T. ; Choi, K.‐H. ; Hwang, Y.‐H. ; Chung, J.‐W. ; Bang, O. Y. ; Kim, G.‐M. ; Seo, W.‐K.</creatorcontrib><description>Background and purpose
We analyzed the incidence and causes of oral anticoagulant (OAC) cessation and subsequent stroke after OAC withdrawal in a cohort of Korean stroke patients with atrial fibrillation.
Methods
The Korean Atrial Fibrillation Evaluation Registry in Ischemic Stroke patients (K‐ATTENTION) is a multicenter cohort study, merging stroke registries from 11 tertiary centers in Korea. The number of OAC interruption episodes and the reasons were reviewed from hospital records. Stroke after OAC withdrawal was defined when a patient experienced ischaemic stroke within 31 days after OAC withdrawal. Clinical variables were compared between patients who experienced stroke recurrence during OAC interruption and those who did not experience recurrence.
Results
Among 3213 stroke patients with atrial fibrillation, a total of 329 episodes of OAC interruption were detected in 229 patients after index stroke (mean age 72.9 ± 8.3 years, 113 female patients). The most frequent reason for OAC withdrawal was poor compliance [103 episodes (31.3%)] followed by extracranial bleeding [96 episodes (29.2%)]. Stroke after OAC withdrawal was noted in 13 patients. Mean age, vascular risk factor profile and mean CHA2DS2‐VASc score were not significantly different between patients with and without recurrent stroke.
Conclusions
A considerable number of stroke patients with atrial fibrillation experienced temporary interruption of OAC after index stroke, which was associated with stroke recurrence of 4.0 cases per 100 interruption episodes.</description><identifier>ISSN: 1351-5101</identifier><identifier>EISSN: 1468-1331</identifier><identifier>DOI: 10.1111/ene.14175</identifier><identifier>PMID: 32064742</identifier><language>eng</language><publisher>England: John Wiley & Sons, Inc</publisher><subject>Anticoagulants ; atrial fibrillation ; Bleeding ; Cardiac arrhythmia ; Electrocardiography ; Fibrillation ; ischaemic stroke ; Ischemia ; oral anticoagulant ; Patients ; Risk analysis ; Risk factors ; Stroke</subject><ispartof>European journal of neurology, 2020-05, Vol.27 (5), p.900-902</ispartof><rights>2020 European Academy of Neurology</rights><rights>2020 European Academy of Neurology.</rights><rights>Copyright © 2020 European Academy of Neurology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3535-4c894eae9d1bf2eae7e9196fc6721b287181757e653c1b736734a22316cc25293</citedby><cites>FETCH-LOGICAL-c3535-4c894eae9d1bf2eae7e9196fc6721b287181757e653c1b736734a22316cc25293</cites><orcidid>0000-0001-7213-5527 ; 0000-0003-3804-0449</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fene.14175$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fene.14175$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32064742$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, J.‐M.</creatorcontrib><creatorcontrib>Park, K.‐Y.</creatorcontrib><creatorcontrib>Yu, I.‐W.</creatorcontrib><creatorcontrib>Song, T.‐J.</creatorcontrib><creatorcontrib>Kim, Y.‐J.</creatorcontrib><creatorcontrib>Kim, B. J.</creatorcontrib><creatorcontrib>Heo, S. H.</creatorcontrib><creatorcontrib>Jung, J.‐M.</creatorcontrib><creatorcontrib>Oh, K.‐M.</creatorcontrib><creatorcontrib>Kim, C. K.</creatorcontrib><creatorcontrib>Yu, S.</creatorcontrib><creatorcontrib>Park, J.‐H.</creatorcontrib><creatorcontrib>Choi, J. C.</creatorcontrib><creatorcontrib>Park, M.‐S.</creatorcontrib><creatorcontrib>Kim, J.‐T.</creatorcontrib><creatorcontrib>Choi, K.‐H.</creatorcontrib><creatorcontrib>Hwang, Y.‐H.</creatorcontrib><creatorcontrib>Chung, J.‐W.</creatorcontrib><creatorcontrib>Bang, O. Y.</creatorcontrib><creatorcontrib>Kim, G.‐M.</creatorcontrib><creatorcontrib>Seo, W.‐K.</creatorcontrib><title>Incidence of oral anticoagulant interruption among stroke patients with atrial fibrillation and subsequent stroke</title><title>European journal of neurology</title><addtitle>Eur J Neurol</addtitle><description>Background and purpose
We analyzed the incidence and causes of oral anticoagulant (OAC) cessation and subsequent stroke after OAC withdrawal in a cohort of Korean stroke patients with atrial fibrillation.
Methods
The Korean Atrial Fibrillation Evaluation Registry in Ischemic Stroke patients (K‐ATTENTION) is a multicenter cohort study, merging stroke registries from 11 tertiary centers in Korea. The number of OAC interruption episodes and the reasons were reviewed from hospital records. Stroke after OAC withdrawal was defined when a patient experienced ischaemic stroke within 31 days after OAC withdrawal. Clinical variables were compared between patients who experienced stroke recurrence during OAC interruption and those who did not experience recurrence.
Results
Among 3213 stroke patients with atrial fibrillation, a total of 329 episodes of OAC interruption were detected in 229 patients after index stroke (mean age 72.9 ± 8.3 years, 113 female patients). The most frequent reason for OAC withdrawal was poor compliance [103 episodes (31.3%)] followed by extracranial bleeding [96 episodes (29.2%)]. Stroke after OAC withdrawal was noted in 13 patients. Mean age, vascular risk factor profile and mean CHA2DS2‐VASc score were not significantly different between patients with and without recurrent stroke.
Conclusions
A considerable number of stroke patients with atrial fibrillation experienced temporary interruption of OAC after index stroke, which was associated with stroke recurrence of 4.0 cases per 100 interruption episodes.</description><subject>Anticoagulants</subject><subject>atrial fibrillation</subject><subject>Bleeding</subject><subject>Cardiac arrhythmia</subject><subject>Electrocardiography</subject><subject>Fibrillation</subject><subject>ischaemic stroke</subject><subject>Ischemia</subject><subject>oral anticoagulant</subject><subject>Patients</subject><subject>Risk analysis</subject><subject>Risk factors</subject><subject>Stroke</subject><issn>1351-5101</issn><issn>1468-1331</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp1kU9P3DAQxa2qVfnTHvoFkKVe6CHgsRM7OSK0FCREL_QcOd4JNc3ai-0I8e0Zmi0HJOYy7_CbN2M_xr6BOAGqUwx4AjWY5gPbh1q3FSgFH0mrBqoGBOyxg5zvhRDSSPGZ7SkpdG1quc8eroLzawwOeRx5THbiNhTvor2bJ1Lch4IpzdviY-B2E8MdzyXFv8i3tngMJfNHX_5wW5Kn4dEPyU-TXfCw5nkeMj7MBO7mvrBPo50yft31Q_b7YnV7flld__p5dX52XTnVqKaqXdvVaLFbwzBKEgY76PTotJEwyNZASw82qBvlYDBKG1VbKRVo52QjO3XIjhffbYq0P5d-47NDui1gnHMvVaO1MLSM0O9v0Ps4p0DXEdVBK2oDgqgfC-VSzDnh2G-T39j01IPoX3LoKYf-Xw7EHu0c52GD61fy_8cTcLoAj37Cp_ed-tXNarF8BgeTkl0</recordid><startdate>202005</startdate><enddate>202005</enddate><creator>Kim, J.‐M.</creator><creator>Park, K.‐Y.</creator><creator>Yu, I.‐W.</creator><creator>Song, T.‐J.</creator><creator>Kim, Y.‐J.</creator><creator>Kim, B. J.</creator><creator>Heo, S. H.</creator><creator>Jung, J.‐M.</creator><creator>Oh, K.‐M.</creator><creator>Kim, C. K.</creator><creator>Yu, S.</creator><creator>Park, J.‐H.</creator><creator>Choi, J. C.</creator><creator>Park, M.‐S.</creator><creator>Kim, J.‐T.</creator><creator>Choi, K.‐H.</creator><creator>Hwang, Y.‐H.</creator><creator>Chung, J.‐W.</creator><creator>Bang, O. Y.</creator><creator>Kim, G.‐M.</creator><creator>Seo, W.‐K.</creator><general>John Wiley & Sons, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7213-5527</orcidid><orcidid>https://orcid.org/0000-0003-3804-0449</orcidid></search><sort><creationdate>202005</creationdate><title>Incidence of oral anticoagulant interruption among stroke patients with atrial fibrillation and subsequent stroke</title><author>Kim, J.‐M. ; Park, K.‐Y. ; Yu, I.‐W. ; Song, T.‐J. ; Kim, Y.‐J. ; Kim, B. J. ; Heo, S. H. ; Jung, J.‐M. ; Oh, K.‐M. ; Kim, C. K. ; Yu, S. ; Park, J.‐H. ; Choi, J. C. ; Park, M.‐S. ; Kim, J.‐T. ; Choi, K.‐H. ; Hwang, Y.‐H. ; Chung, J.‐W. ; Bang, O. Y. ; Kim, G.‐M. ; Seo, W.‐K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3535-4c894eae9d1bf2eae7e9196fc6721b287181757e653c1b736734a22316cc25293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Anticoagulants</topic><topic>atrial fibrillation</topic><topic>Bleeding</topic><topic>Cardiac arrhythmia</topic><topic>Electrocardiography</topic><topic>Fibrillation</topic><topic>ischaemic stroke</topic><topic>Ischemia</topic><topic>oral anticoagulant</topic><topic>Patients</topic><topic>Risk analysis</topic><topic>Risk factors</topic><topic>Stroke</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, J.‐M.</creatorcontrib><creatorcontrib>Park, K.‐Y.</creatorcontrib><creatorcontrib>Yu, I.‐W.</creatorcontrib><creatorcontrib>Song, T.‐J.</creatorcontrib><creatorcontrib>Kim, Y.‐J.</creatorcontrib><creatorcontrib>Kim, B. J.</creatorcontrib><creatorcontrib>Heo, S. H.</creatorcontrib><creatorcontrib>Jung, J.‐M.</creatorcontrib><creatorcontrib>Oh, K.‐M.</creatorcontrib><creatorcontrib>Kim, C. K.</creatorcontrib><creatorcontrib>Yu, S.</creatorcontrib><creatorcontrib>Park, J.‐H.</creatorcontrib><creatorcontrib>Choi, J. C.</creatorcontrib><creatorcontrib>Park, M.‐S.</creatorcontrib><creatorcontrib>Kim, J.‐T.</creatorcontrib><creatorcontrib>Choi, K.‐H.</creatorcontrib><creatorcontrib>Hwang, Y.‐H.</creatorcontrib><creatorcontrib>Chung, J.‐W.</creatorcontrib><creatorcontrib>Bang, O. Y.</creatorcontrib><creatorcontrib>Kim, G.‐M.</creatorcontrib><creatorcontrib>Seo, W.‐K.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, J.‐M.</au><au>Park, K.‐Y.</au><au>Yu, I.‐W.</au><au>Song, T.‐J.</au><au>Kim, Y.‐J.</au><au>Kim, B. J.</au><au>Heo, S. H.</au><au>Jung, J.‐M.</au><au>Oh, K.‐M.</au><au>Kim, C. K.</au><au>Yu, S.</au><au>Park, J.‐H.</au><au>Choi, J. C.</au><au>Park, M.‐S.</au><au>Kim, J.‐T.</au><au>Choi, K.‐H.</au><au>Hwang, Y.‐H.</au><au>Chung, J.‐W.</au><au>Bang, O. Y.</au><au>Kim, G.‐M.</au><au>Seo, W.‐K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incidence of oral anticoagulant interruption among stroke patients with atrial fibrillation and subsequent stroke</atitle><jtitle>European journal of neurology</jtitle><addtitle>Eur J Neurol</addtitle><date>2020-05</date><risdate>2020</risdate><volume>27</volume><issue>5</issue><spage>900</spage><epage>902</epage><pages>900-902</pages><issn>1351-5101</issn><eissn>1468-1331</eissn><abstract>Background and purpose
We analyzed the incidence and causes of oral anticoagulant (OAC) cessation and subsequent stroke after OAC withdrawal in a cohort of Korean stroke patients with atrial fibrillation.
Methods
The Korean Atrial Fibrillation Evaluation Registry in Ischemic Stroke patients (K‐ATTENTION) is a multicenter cohort study, merging stroke registries from 11 tertiary centers in Korea. The number of OAC interruption episodes and the reasons were reviewed from hospital records. Stroke after OAC withdrawal was defined when a patient experienced ischaemic stroke within 31 days after OAC withdrawal. Clinical variables were compared between patients who experienced stroke recurrence during OAC interruption and those who did not experience recurrence.
Results
Among 3213 stroke patients with atrial fibrillation, a total of 329 episodes of OAC interruption were detected in 229 patients after index stroke (mean age 72.9 ± 8.3 years, 113 female patients). The most frequent reason for OAC withdrawal was poor compliance [103 episodes (31.3%)] followed by extracranial bleeding [96 episodes (29.2%)]. Stroke after OAC withdrawal was noted in 13 patients. Mean age, vascular risk factor profile and mean CHA2DS2‐VASc score were not significantly different between patients with and without recurrent stroke.
Conclusions
A considerable number of stroke patients with atrial fibrillation experienced temporary interruption of OAC after index stroke, which was associated with stroke recurrence of 4.0 cases per 100 interruption episodes.</abstract><cop>England</cop><pub>John Wiley & Sons, Inc</pub><pmid>32064742</pmid><doi>10.1111/ene.14175</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0001-7213-5527</orcidid><orcidid>https://orcid.org/0000-0003-3804-0449</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1351-5101 |
| ispartof | European journal of neurology, 2020-05, Vol.27 (5), p.900-902 |
| issn | 1351-5101 1468-1331 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2356607353 |
| source | Access via Wiley Online Library |
| subjects | Anticoagulants atrial fibrillation Bleeding Cardiac arrhythmia Electrocardiography Fibrillation ischaemic stroke Ischemia oral anticoagulant Patients Risk analysis Risk factors Stroke |
| title | Incidence of oral anticoagulant interruption among stroke patients with atrial fibrillation and subsequent stroke |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T05%3A35%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incidence%20of%20oral%20anticoagulant%20interruption%20among%20stroke%20patients%20with%20atrial%20fibrillation%20and%20subsequent%20stroke&rft.jtitle=European%20journal%20of%20neurology&rft.au=Kim,%20J.%E2%80%90M.&rft.date=2020-05&rft.volume=27&rft.issue=5&rft.spage=900&rft.epage=902&rft.pages=900-902&rft.issn=1351-5101&rft.eissn=1468-1331&rft_id=info:doi/10.1111/ene.14175&rft_dat=%3Cproquest_cross%3E2391804710%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2391804710&rft_id=info:pmid/32064742&rfr_iscdi=true |